Funding for this research was provided by:
Sackler Institute for Translational Neurodevelopment, King's College London
Medical Research Council (MR/N026063/1)
GW Research Ltd
National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) At SLAM NHS Foundation Trust and King's College London
Innovative Medicines Initiative 2 Joint Undertaking (Grant agreement No 777394 for the project AIMS-2-TRIALS)
Received: 8 February 2021
Accepted: 17 June 2021
First Online: 1 July 2021
: The King’s College London Research Ethics Committee provided institutional ethical approval for this study (reference HR15/162744). All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.